GlaxoSmithKline PLC Director/PDMR Shareholding (5967Z)
13 Gennaio 2020 - 11:34AM
UK Regulatory
TIDMGSK
RNS Number : 5967Z
GlaxoSmithKline PLC
13 January 2020
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Ms E Walmsley
==== ====================================== =================================================
b) Position/status Chief Executive Officer
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 18
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr R Connor
==== ====================================== =================================================
b) Position/status President, Global Vaccines
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 60
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr N Hirons
==== ====================================== =================================================
b) Position/status SVP, Global Ethics & Compliance
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 13
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Ms S Jackson
==== ====================================== =================================================
b) Position/status SVP, Global Communications and CEO Office
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 54
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Mr D Jackson
==== ====================================== =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
and CEO Office)
==== ====================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =====================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== =====================
GBP17.9284 19
======================================================================= =====================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
==================================================================== ============================
e) Date of the transaction 2020-01-09
==== ====================================== =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr L Miels
==== ====================================== =================================================
b) Position/status President, Global Pharmaceuticals
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 4
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr D Redfern
==== ====================================== =================================================
b) Position/status Chief Strategy Officer
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 67
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr R Simard
==== ====================================== =================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 19
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr P C Thomson
==== ====================================== =================================================
b) Position/status President, Global Affairs
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 39
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Ms D Waterhouse
==== ====================================== =================================================
b) Position/status Chief Executive Officer of ViiV Healthcare
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 53
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Ms V A Whyte
==== ====================================== =================================================
b) Position/status Company Secretary
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 January 2020, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.9284 49
===================================================================== ===================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2020-01-09
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBXLFFBFLXBBF
(END) Dow Jones Newswires
January 13, 2020 05:34 ET (10:34 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024
